Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam'β-Lactamase Inhibitor Combinations

Journal of Clinical Microbiology

Volumn 54, Issue 3, 2016, Pages 791-794

  Thomson, Gina K ^a,b   Snyder, James W ^b   McElheny, Christi L ^c   Thomson, Kenneth S ^b   Doi, Yohei ^c  

^a UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AVIBACTAM; AVIBACTAM PLUS CEFTAZIDIME; AZTREONAM; BETA LACTAM; BETA LACTAMASE INHIBITOR; CARBAPENEM; CARBAPENEMASE; CARBAPENEMASE KPC 18; CARBAPENEMASE VIM 1; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; ENTEROBACTER CLOACAE; ENZYME SYNTHESIS; GENE LOCATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UNITED STATES; BIOSYNTHESIS; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENE LOCUS; GENE ORDER; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASE INHIBITORS; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; GENE ORDER; GENETIC LOCI; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84959570300     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02739-15     Document Type: Article

References (24)

1. Pitout JD, Nordmann P, Poirel L. 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873-5884. doihttp://dx.doi.org/10.1128/AAC.01019-15.
2. Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. 2014. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 20:862-872. http://dx.doi.org/10.1111/1469-0691.12697.
3. Drawz SM, Papp-Wallace KM, Bonomo RA. 2014. New-lactamase inhibitors: A therapeutic renaissance in an MDR world. Antimicrob Agents Chemother 58:1835-1846. http://dx.doi.org/10.1128/AAC .00826-13.
4. Vasoo S, Cunningham SA, Cole NC, Kohner PC, Menon SR, Krause KM, Harris KA, De PP, Koh TH, Patel R. 2015. In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing Gram-negative bacilli. Antimicrob Agents Chemother 59:7842-7846. http://dx.doi.org/10.1128/AAC.02019-15.
5. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. 2005. First nosocomial outbreak of Pseudomonas aeruginosa producing an integronborne metallo-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother 49:3538-3540. http://dx.doi.org/10.1128/AAC.49.8 .3538-3540.2005.
6. Epson EE, Pisney LM, Wendt JM, MacCannell DR, Janelle SJ, Kitchel B, Rasheed JK, Limbago BM, Gould CV, Kallen AJ, Barron MA, Bamberg WM. 2014. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol 35:390-397. http://dx.doi.org/10.1086/675607.
7. Epstein L, Hunter JC, Arwady MA, Tsai V, Stein L, Gribogiannis M, Frias M, Guh AY, Laufer AS, Black S, Pacilli M, Moulton-Meissner H, Rasheed JK, Avillan JJ, Kitchel B, Limbago BM, MacCannell D, Lonsway D, Noble-Wang J, Conway J, Conover C, Vernon M, Kallen AJ. 2014. New Delhi metallo-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 312: 1447-1455. http://dx.doi.org/10.1001/jama.2014.12720.
8. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Kim SY, Hong SG, Moland ES, Thomson KS. 2007. Convenient test using a combination of chelating agents for detection of metallo-lactamases in the clinical laboratory. J Clin Microbiol 45:2798-2801. http://dx.doi.org/10.1128/JCM.02486-06.
10. Thomson GK, AbdelGhani S, Snyder JW, Thomson KS. 2015. Indirect Tris-EDTA disk testing using imipenem and meropenem for detection of OXA-48 carbapenemase production. J Clin Microbiol 53:3705-3706. http://dx.doi.org/10.1128/JCM.02094-15.
11. Abdelhamed AM, Bajaksouzian S, Bonomo RA, Jacobs MR. 2015. Evaluation of Verigene BC-GN for identification of Gram negative bacteria and detection of resistance to-lactams, including carbapenems from solid media, poster D-1153. Abstr 55th Intersci Conf Antimicrob Agents Chemother, San Diego, CA.
12. Porres-Osante N, Azcona-Gutierrez JM, Rojo-Bezares B, Undabeitia E, Torres C, Saenz Y. 2014. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain. J Antimicrob Chemother 69:1792-1795. http://dx.doi.org/10.1093/jac/dku055.
13. Steinmann J, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, Paul A, Saner F, Buer J, Rath P. 2011. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill 16:pii-19944. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-19944.
14. Rojas LJ, Mojica MF, Blanco VM, Correa A, Montealegre MC, De La Cadena E, Maya JJ, Camargo RD, Quinn JP, Villegas MV. 2013. Emergence of Klebsiella pneumoniae coharboring KPC and VIM carbapenemases in Colombia. Antimicrob Agents Chemother 57:1101-1102. http://dx.doi.org/10.1128/AAC.01666-12.
15. Meletis G, Tzampaz E, Protonotariou E, Sofianou D. 2010. Emergence of Klebsiella pneumoniae carrying blaVIM and blaKPC genes. Hippokratia 14:139-140. http://dx.doi.org/10.3109/23744235.2015.1094822.
16. Markovska R, Schneider I, Stoeva T, Bojkova K, Boyanova L, Bauernfeind A, Mitov I. 2013. First identification of KPC-2 and VIM-1 producing Klebsiella pneumoniae in Bulgaria. Diagn Microbiol Infect Dis 77:252-253. http://dx.doi.org/10.1016/j.diagmicrobio.2013.07.019.
17. Izdebski R, Baraniak A, Herda M, Fiett J, Bonten MJ, Carmeli Y, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M, MOSAR WP2, WP3, and WP5 Study Groups. 2015. MLST reveals potentially high-risk international clones of Enterobacter cloacae. J Antimicrob Chemother 70:48-56. http://dx.doi.org/10.1093/jac/dku359.
18. Adams-Haduch JM, Potoski BA, Sidjabat HE, Paterson DL, Doi Y. 2009. Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 53:2700-2701. http://dx.doi.org/10.1128/AAC.00290-09.
19. Conlan S, Thomas PJ, Deming C, Park M, Lau AF, Dekker JP, Snitkin ES, Clark TA, Luong K, Song Y, Tsai YC, Boitano M, Dayal J, Brooks SY, Schmidt B, Young AC, Thomas JW, Bouffard GG, Blakesley RW, Program NCS, Mullikin JC, Korlach J, Henderson DK, Frank KM, Palmore TN, Segre JA. 2014. Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med 6:254ra126. http://dx.doi.org/10.1126/scitranslmed.3009845.
20. Chen L, Chavda KD, DeLeo FR, Bryant KA, Jacobs MR, Bonomo RA, Kreiswirth BN. 2015. Genome sequence of a Klebsiella pneumoniae sequence type 258 isolate with prophage-encoded K. Pneumoniae carbapenemase. Genome Announc 3:pii-e00659-15. http://dx.doi.org/10.1128/genomeA.00659-15.
21. Martinez T, Vazquez GJ, Aquino EE, Martinez I, Robledo IE. 2014. ISEcp1-mediated transposition of blaKPC into the chromosome of a clinical isolate of Acinetobacter baumannii from Puerto Rico. J Med Microbiol 63:1644-1648. http://dx.doi.org/10.1099/jmm.0.080721-0.
22. Miriagou V, Papagiannitsis CC, Kotsakis SD, Loli A, Tzelepi E, Legakis NJ, Tzouvelekis LS. 2010. Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-lactamase gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 54:4497-4502. http://dx.doi.org/10.1128/AAC.00665-10.
23. Franceschini N, Caravelli B, Docquier JD, Galleni M, Frere JM, Amicosante G, Rossolini GM. 2000. Purification and biochemical characterization of the VIM-1 metallo-lactamase. Antimicrob Agents Chemother 44:3003-3007. http://dx.doi.org/10.1128/AAC.44.11.3003-3007 .2000.
24. Kazmierczak KM, Rabine S, Hackel M, McLaughlin RE, Biedenbach DJ, Bouchillon SK, Sahm DF, Bradford PA. 2015. Multi-year, multi-national survey of the incidence and global distribution of metallo-lactamaseproducing Enterobacteriaceae and P. Aeruginosa. Antimicrob Agents Chemother. Epub ahead of print.